Indication: For mild and moderate infections caused by sensitive bacteria. Upper respiratory tract infection, purulent streptococcal pharyngitis/tonsillitis. Note: Intramuscular penicillin should be selected for the treatment and prevention of streptococcal infections (including the prevention of rheumatic fever). Although cefprozil is generally effective in clearing purulent streptococci in the nasopharynx, there is currently no data available for the use of cefprozil in the prevention of secondary rheumatic fever. Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains), and Moraxella catarrhalis (including β-lactamase-producing strains). Acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains), and Moraxella catarrhalis (including β-lactamase-producing strains). Lower respiratory tract infection, secondary bacterial infection of acute bronchitis and acute exacerbation of chronic bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains), and Moraxella catarrhalis (including β-lactamase-producing strains). Skin and skin tissue infections caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes are uncomplicated, but abscesses usually require surgical drainage.

Indication: It is used for the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infection. 2. Lower respiratory tract infection. 3. Skin and skin soft tissue infection.

Indication: It is used for the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infection. 2. Lower respiratory tract infection. 3. Skin and skin soft tissue infection.

Indication: For the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infections (1) Pharyngitis/tonsillitis caused by Streptococcus pyogenes. Note: Intramuscular penicillin should usually be used to treat and prevent streptococcal infections (including prevention of rheumatic fever). Although cefuroxime can generally effectively eliminate Streptococcus pyogenes in the nasopharynx, there is currently no data available for the use of cefuroxime to prevent secondary rheumatic fever. (2) Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains). Acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains). 2. Lower respiratory tract infections caused by Streptococcus pneumoniae, Haemophilus influenzae (including

Indication: For the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infection, Streptococcus pyogenes pharyngitis/tonsillitis. Note: Intramuscular penicillin should usually be used to treat and prevent streptococcal infections (including prevention of rheumatic fever). Although cefprozil can generally effectively eliminate Streptococcus pyogenes in the nasopharynx, there is currently no reference data on the use of cefprozil to prevent secondary rheumatic fever. Otitis media and acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains). 2. Lower respiratory tract infection, secondary bacterial infection of acute bronchitis and acute exacerbation of chronic bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains). 3. Uncomplicated skin and skin soft tissue infections caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes, but abscesses usually require surgical drainage. Bacterial culture and drug sensitivity testing should be performed when appropriate to determine the sensitivity of the pathogen to cefprozil.

Indication: For the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infections (1) pharyngitis and tonsillitis caused by purulent streptococci; (2) otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains); acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains); 2. Lower respiratory tract infections caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains); acute bronchitis secondary to bacterial infection caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains);

Indication: 1. For the following mild and moderate infections caused by sensitive bacteria: upper respiratory tract infection, purulent streptococcal pharyngitis/tonsillitis; 2. Intramuscular penicillin should be selected for the usual treatment and prevention of streptococcal infections (including the prevention of rheumatic fever); although cefoperazone can generally effectively eliminate purulent streptococci in the nasopharynx, there is currently no reference data on the use of cefoperazone to prevent secondary rheumatic fever; otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae (including (-lactamase-producing strains) and Moraxella catarrhalis (including (-lactamase-producing strains); acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including (-lactamase-producing strains) and Moraxella catarrhalis (including (-lactamase-producing strains); lower respiratory tract infections caused by Streptococcus pneumoniae

Indication: For the following mild and moderate infections caused by sensitive bacteria: 1. Upper respiratory tract infection, Streptococcus pyogenes pharyngitis/tonsillitis. Note: Intramuscular penicillin should usually be used to treat and prevent streptococcal infections (including prevention of rheumatic fever). Although cefprozil can generally effectively eliminate Streptococcus pyogenes in the nasopharynx, there is currently no reference data on the use of cefprozil to prevent secondary rheumatic fever. Otitis media and acute sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains). 2. Lower respiratory tract infection, secondary bacterial infection of acute bronchitis and acute exacerbation of chronic bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase-producing strains) and Moraxella catarrhalis (including β-lactamase-producing strains). 3. Uncomplicated skin and skin soft tissue infections caused by Staphylococcus aureus (including penicillinase-producing strains) and Streptococcus pyogenes, but abscesses usually require surgical drainage. Bacterial culture and drug sensitivity testing should be performed when appropriate to determine the sensitivity of the pathogen to cefprozil.

Indication: 1. This product is used as the first choice or optional drug for the following diseases. (1) Rickettsial diseases, including epidemic typhus, endemic typhus, Rocky Mountain fever, scrub typhus and Q fever. (2) Mycoplasma infections. (3) Chlamydia infections, including psittacosis, venereal diseases, lymphoedema, nonspecific urethritis, salpingitis, cervicitis and trachoma. (4) Relapsing fever. (5) Brucellosis. (6) Cholera. (7) Tularemia. (8) Plague. (9) Chancroid. Brucellosis and plague need to be treated with aminoglycosides. 2. Due to the serious resistance of common pathogens to tetracyclines, this type of drug is only indicated when the pathogen is sensitive to this product. This product is also not suitable for the treatment of hemolytic streptococcal infections and any type of staphylococcal infections. 3. This product can be used for patients with tetanus, gas gangrene, yaws, syphilis, gonorrhea, leptospirosis, actinomycetes and Listeria monocytogenes who are allergic to penicillins.

Indication: 1. This product is used as the first choice or optional drug for the following diseases. (1) Rickettsial diseases, including epidemic typhus, endemic typhus, Rocky Mountain fever, scrub typhus and Q fever. (2) Mycoplasma infections. (3) Chlamydia infections, including psittacosis, venereal diseases, lymphoedema, nonspecific urethritis, salpingitis, cervicitis and trachoma. (4) Relapsing fever. (5) Brucellosis. (6) Cholera. (7) Tularemia. (8) Plague. (9) Chancroid. Brucellosis and plague need to be treated with aminoglycosides. 2. Due to the serious resistance of common pathogens to tetracyclines, this type of drug is only indicated when the pathogen is sensitive to this product. This product is also not suitable for the treatment of hemolytic streptococcal infections and any type of staphylococcal infections. 3. This product can be used for patients with tetanus, gas gangrene, yaws, syphilis, gonorrhea, leptospirosis, actinomycetes and Listeria monocytogenes who are allergic to penicillins.